# Iodine Supplementation on Breast Cancer

> **NCT03688958** · PHASE2 · UNKNOWN · sponsor: **Universidad Nacional Autonoma de Mexico** · enrollment: 120 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Placebo
- **DRUG:** iodine
- **DRUG:** FEC/TE Placebo
- **DRUG:** FEC/TE iodine

## Key facts

- **NCT ID:** NCT03688958
- **Lead sponsor:** Universidad Nacional Autonoma de Mexico
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-03-15
- **Primary completion:** 2009-12-01
- **Final completion:** 2020-06
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2018-09-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03688958

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03688958, "Iodine Supplementation on Breast Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03688958. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*